SCHEMBL17742411

CC1C(O)[C@H](O[C@@H]2OC(CO[C@]3(C(=O)O)C[C@@H](O)[C@@H](N)C([C@H](O)[C@H](O)CO)O3)[C@H](O)C(O)[C@@H]2O)[C@H](CO)O[C@H]1O[C@@H]1C(O)[C@H](O)C(CO)O[C@@H]1OCC1O[C@@H](O[C@@H]2C(CO)O[C@@H](O[C@@H]3C(CO)O[C@@H](NC(=O)CBr)[C@@H](C)C3O)[C@@H](C)C2O)[C@H](O)C(O[C@H]2O[C@H](CO)[C@@H](O)C(O)C2O[C@@H]2OC(CO)[C@@H](O[C@@H]3OC(CO[C@]4(C(=O)O)C[C@@H](O)[C@@H](N)C(C5C(O)[C@H]5O)O4)[C@H](O)C(O)[C@@H]3O)C(O)[C@@H]2C)[C@@H]1O

nearest known ligand 0.49

Predicted protein targets (top 7)

	gene	UniProt	supporting neighbours	confidence
▸	SIGLEC7	Q9Y286	6/20	0.49

▸	CD209	Q9NNX6	1/20	0.45

▸	MAG	P20916	5/20	0.43

▸	SELP	P16109	2/20	0.39

▸	SELL	P14151	1/20	0.39

▸	CD22	P20273	4/20	0.36

▸	SELE	P16581	1/20	0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL17546142	0.97	SIGLEC7 (0.50)	SIGLEC7CD209MAGSELPSELL
SCHEMBL18333611	0.97	SIGLEC7 (0.50)	SIGLEC7CD209MAGSELPSELL
SCHEMBL17199689	0.97	SIGLEC7 (0.50)	SIGLEC7CD209MAGSELPSELL
SCHEMBL16190402	0.96	SIGLEC7 (0.44)	SIGLEC7CD209MAGSELPSELL
SCHEMBL16348275	0.96	SIGLEC7 (0.44)	SIGLEC7CD209MAGSELPSELL
SCHEMBL16190425	0.91	SIGLEC7 (0.44)	SIGLEC7CD209MAGSELPSELL
SCHEMBL18333657	0.91	SIGLEC7 (0.44)	SIGLEC7CD209MAGSELPSELL
SCHEMBL17546166	0.91	SIGLEC7 (0.46)	SIGLEC7CD209MAGSELPSELL
SCHEMBL17546151	0.91	SIGLEC7 (0.50)	SIGLEC7CD209MAGSELPSELL
SCHEMBL18333573	0.90	SIGLEC7 (0.47)	SIGLEC7CD209MAGSELPSELL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-20160129150-A1	SUGAR CHAIN-POLYPEPTIDE COMPLEX	GLYTECH, INC. (JP)	2016-05-12	—	—	US	disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

Patent	Title	Text reads most about	Predicted target · text-rank
US-20160129150-A1	SUGAR CHAIN-POLYPEPTIDE COMPLEX	IAPP, ENPEP, QPCTL	SIGLEC7 34/4885CD209 910/4885MAG 2349/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.